Rural Health Access Initiative (RHAI)

We deliver education on AMR to rural medical retail outlets, empowering them to comprehend the consequences of antibiotic overuse.

Godfrey Lameck

In Tanzania, access to essential medicines is primarily through local drug shops called duka la dawa baridi. However, many of these shops illegally sell prescription drugs, despite regulations prohibiting it. With over 5,600 registered stores in 2013, they serve as the main source of medicines, especially in rural areas where licensed pharmacies are scarce. Given the prevalent practice of self-diagnosis and medication, these shops become the most accessible option for obtaining medicines, particularly for common ailments like malaria and diarrhea. This reliance underscores the urgent need to address antibiotic misuse and antimicrobial resistance (AMR) in rural drug shops. Our project aims to equip these shops with the knowledge and resources to understand the consequences of antibiotic misuse, thereby safeguarding antibiotic effectiveness and protecting public health in underserved communities.

Our solution primarily serves rural and periurban communities in Tanzania, where access to healthcare services, including essential medicines, is limited. The target audience includes individuals who rely on local drug shops, known as duka la dawa baridi, for obtaining medicines and seeking health advice. We aim to support them by addressing the challenge of antibiotic misuse and antimicrobial resistance (AMR) within these communities.

To understand their needs, we conduct community surveys, interviews, and focus group discussions to gather insights into their healthcare-seeking behaviors, perceptions of antibiotic use, and knowledge of AMR. Additionally, we collaborate with local health authorities, community leaders, and healthcare workers to gain a deeper understanding of the specific challenges faced by the target audience.

As we develop the solution, we actively engage the target audience through participatory workshops, educational sessions, and awareness campaigns. By involving community members in the design and implementation of our interventions, we ensure that our solution is culturally appropriate, contextually relevant, and responsive to their needs and preferences. Through ongoing dialogue and feedback mechanisms, we continually refine and adapt our approach to better meet the needs of the communities we serves

Knowledge and Education: We offer educational materials and training sessions to rural drug shop owners and caretakers, increasing awareness and understanding of antimicrobial resistance (AMR) and appropriate antibiotic use. By disseminating evidence-based information on AMR prevention and control, we contribute to the public good of knowledge dissemination and health literacy.

Behavioral Change: Through our interventions, we promote behavior change among drug shop owners and caretakers, encouraging responsible antibiotic stewardship and adherence to treatment guidelines. By fostering positive health behaviors, we contribute to the public good of promoting community health and well-being.

Our solution aims to create tangible impact by empowering rural drug shops in Tanzania with the knowledge and resources necessary to address the misuse of antibiotics and combat antimicrobial resistance (AMR). By providing targeted education and training sessions to drug shop owners and staff, we expect to improve their understanding of proper antibiotic prescribing and dispensing practices, as well as the consequences of antibiotic misuse. 

The impact of our solution will be felt by multiple stakeholders:

Rural Communities: Improved antibiotic stewardship in rural drug shops will directly benefit community members by reducing the risk of acquiring antibiotic-resistant infections. With access to appropriate antibiotics when needed and guidance on their proper use, individuals will experience better health outcomes and reduced treatment failures. 

Drug Shop Owners and Staff: By equipping drug shop owners and staff with the knowledge and skills to implement evidence-based practices, our solution will enhance their professional capabilities and increase their confidence in delivering quality healthcare services. This may lead to improved reputations for their establishments and increased customer trust and loyalty.

Expansion of Training Program: In the next year, we will expand our training program to reach a larger number of rural drug shop owners across multiple regions. We will collaborate with local health authorities, community leaders, and non-governmental organizations (NGOs) to identify target communities and facilitate training sessions. Over the next three years, we aim to establish a comprehensive training network that covers all rural areas where drug shops are prevalent, ensuring widespread adoption of best practices in antibiotic stewardship.

Digital Learning Platform: To reach a broader audience and facilitate continuous learning among drug shop owners, we will develop a digital learning mobile app that offers interactive training modules, educational resources, and real-time support. This platform will enable us to scale our training program beyond physical workshops and provide ongoing support to participants. Over the next three years, we will enhance the App with additional features such as virtual simulations, peer-to-peer learning communities, and access to expert consultations.

Community Outreach and Awareness Campaigns: In addition to training drug shop owners, we will launch community outreach and awareness campaigns to educate the general public about the importance of responsible antibiotic use and AMR prevention. 

Our organization is measuring success against our impact goals through a comprehensive monitoring and evaluation (M&E) framework designed to track progress, assess outcomes, and refine strategies as needed. Key components of our M&E plan include:

Antibiotic Sales and Prescribing Patterns: We are monitoring changes in antibiotic sales and prescribing patterns in rural drug shops over time. By comparing data collected before and after the implementation of our intervention, we can assess the impact of our educational efforts on antibiotic use practices. For example, we aim to see a decrease in the proportion of antibiotics sold without a prescription and an increase in adherence to treatment guidelines among drug shop owners.

Knowledge and Attitude Surveys: We are conducting pre- and post-intervention surveys to assess changes in knowledge and attitudes towards antimicrobial resistance (AMR) among drug shop owners and caretakers. These surveys include questions related to AMR awareness, antibiotic use practices, and perceptions of the importance of responsible antibiotic stewardship. By tracking changes in survey responses over time, we can gauge the effectiveness of our educational interventions in improving understanding and fostering positive attitudes towards AMR prevention.

Financial Constraints: Limited funding poses a significant barrier to scaling our impact over the coming years. Securing sufficient financial resources is essential to sustain our operations, expand our reach to additional rural communities, and invest in staff capacity building and programmatic enhancements. To overcome this barrier, we plan to pursue diverse funding sources, including grants from international development agencies, philanthropic organizations, and corporate partnerships. Additionally, we will explore opportunities for social impact investment and seek to establish sustainable revenue streams through fee-for-service models or product sales. 

Technical Challenges: Implementing educational interventions in rural drug shops requires overcoming various technical challenges, including limited access to technology and internet connectivity, as well as language and literacy barriers among target populations. To address these challenges, we will develop tailored training materials and tools that are accessible and culturally appropriate for rural drug shop owners and caretakers. We will also leverage offline training methods, such as in-person workshops and printed materials, to deliver education in areas with limited technological infrastructure.

We are applying to The Trinity Challenge because we recognize the immense value of collaborating with a global network of organizations and experts dedicated to addressing pressing health challenges, particularly antimicrobial resistance (AMR). By participating in The Trinity Challenge, we aim to leverage the collective expertise, resources, and innovative solutions offered by the network to advance our efforts in combatting AMR in Tanzania.

One of the primary barriers we face in our work is the limited access to funding and resources needed to implement and scale our solution effectively. The Trinity Challenge provides a unique opportunity to access funding, technical support, and mentorship from leading institutions and experts in the field, enabling us to overcome financial barriers and accelerate the impact of our initiatives.

Additionally, we recognize the importance of collaboration and knowledge sharing in addressing complex health challenges such as AMR. By participating in The Trinity Challenge, we hope to connect with like-minded organizations and experts who can offer valuable insights, best practices, and partnerships to enhance the effectiveness and sustainability of our programs.

World Health Organization (WHO): As a leading global health authority, WHO's expertise and resources could greatly enhance our solution's reach and impact. Collaboration with WHO could facilitate the dissemination of our solution to a broader audience, leveraging their extensive network of healthcare professionals and policymakers. WHO's guidance on antimicrobial resistance (AMR) policies and best practices would provide valuable insights for refining our approach and ensuring alignment with global health priorities.

Médecins Sans Frontières (Doctors Without Borders): MSF operates in some of the world's most challenging environments, providing medical assistance where it is needed most. Partnering with MSF would enable us to implement our solution in underserved and crisis-affected communities, where the burden of AMR is often most severe. By leveraging MSF's operational expertise and field presence, we can deliver targeted interventions and build local capacity to address AMR effectively.

Centers for Disease Control and Prevention (CDC): CDC plays a pivotal role in global efforts to combat infectious diseases and antimicrobial resistance. Collaboration with CDC would provide access to cutting-edge research, surveillance data, and technical expertise in AMR prevention and control.